XML 115 R125.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Information 2 (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Segment Reporting Information [Line Items]                      
Premiums and fees and other revenues                 $ 29,176 $ 26,308 $ 19,210
Net investment income                 1,164 1,144 1,146
Total revenues 8,151 8,066 7,980 8,183 7,620 7,323 7,422 6,754 32,380 29,119 21,865
Depreciation and amortization                 597 560 345
Income taxes                 698 853 615
Segment earnings 361 [1] 553 505 [2] 57 [3] 406 [4] 466 [5] 380 [6] 371 [7] 1,476 1,623 1,260
Operating Segments [Member]
                     
Segment Reporting Information [Line Items]                      
Segment earnings                 1,335 1,592 1,219
Run-off Reinsurance [Member]
                     
Segment Reporting Information [Line Items]                      
Premiums and fees and other revenues                 (38) (98) 20
Net investment income                 19 102 103
Total revenues                 (19) 4 123
Depreciation and amortization                 0 0 0
Income taxes                 (262) 0 (99)
Segment earnings                 (488) 0 (183)
Other Operations Segment [Member]
                     
Segment Reporting Information [Line Items]                      
Premiums and fees and other revenues                 152 155 169
Net investment income                 389 388 400
Total revenues                 541 543 569
Depreciation and amortization                 1 1 2
Income taxes                 25 43 29
Segment earnings                 $ 94 $ 82 $ 89
[1] The fourth quarter of 2013 includes an after-tax charge of $40 million for an organizational efficiency plan.
[2] The second quarter of 2013 includes an after-tax charge of $24 million for the Pharmacy Benefits Manager (“PBM”) partnering agreement with Catamaran.
[3] The first quarter of 2013 includes an after-tax gain of $25 for the GMIB business, an after-tax charge of $507 million for the transaction with Berkshire to effectively exit the Run-off Reinsurance business, and an after-tax charge of $51 million related to the disability claims regulatory matter in the Group Disability and Life segment.
[4] The fourth quarter of 2012 includes an after-tax gain of $7 million for the GMIB business and an after-tax charge of $68 million for litigation matters.
[5] The third quarter of 2012 includes an after-tax gain of $32 million for the GMIB business, an after-tax charge of $12 million for costs associated with acquisitions, and an after-tax charge of $50 million for costs associated with an organizational efficiency plan.
[6] The second quarter of 2012 includes an after-tax loss of $51 million for the GMIB business.
[7] The first quarter of 2012 includes an after-tax gain of $41 million for the GMIB business, an after-tax charge of $28 million for costs associated with acquisitions, and an after-tax charge of $13 million for costs associated a litigation matter in Global Health Care.